Navigation Links
Unlocking the genetic mysteries behind stillbirth
Date:12/6/2012

the Stillbirth Network.

The researchers compared the results of karyotypes from more than 500 stillbirths to results from microarray analysis, a method that detects small segments of missing parts of chromosomes (deletions) or additional sections of genetic material (duplications) that cannot be seen by karyotyping.

They analyzed samples from all stillbirths in a population-based study in five U.S. areas, covered by 59 hospitals over a period of two and a half years. Shortly after each stillbirth, parents gave research staff permission to collect blood from the umbilical cord and tissue from the fetus and the placenta.

The UTMB research team's goal was to reach the parents of 90 percent of all stillborn babies to residents of Galveston and Brazoria counties during the time period of the study. To achieve this, they formed partnerships with 11 hospitals in the region and developed a methodology whereby stillbirths were reported immediately to UTMB if the stillborn child's parents granted permission. Upon notification, UTMB sent staff members to the hospital to meet with the bereaved families.

If the families agreed to take part in the study, UTMB staff members then worked with the participating hospitals to transport the babies to Galveston for genetic testing and/or autopsy before arranging with funeral homes for the babies' final transport. About 100 stillbirths occurred in the Galveston/Brazoria county region during the two and a half years the study took place.

"It's really something, that families in such a tough situation, with all the shock and sadness they must be feeling upon the loss of their baby, would be willing to work with us to conduct this important stillbirth research," said Saade.

The hospitals included in the UTMB arm of the study were Angleton Danbury Medical Center, Brazosport Memorial Hospital, Clear Lake Regional Medical Center, Memorial Hermann Hospital, Mainland Medical Center, Methodist H
'/>"/>

Contact: Molly Dannenmaier
mjdannen@utmb.edu
409-771-5105
University of Texas Medical Branch at Galveston
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Unlocking the secrets of DNA repair
2. New evidence for epigenetic effects of diet on healthy aging
3. Genetic data shows that skin cancer risk includes more than UV exposure
4. Genetics Society of Americas Genetics journal highlights for December 2012
5. McKinney Orthodontics Educates on New Evidence that Crooked Teeth are Genetic
6. Genetic factor holds key to blood vessel health
7. A new factor of genetic susceptibility to Alzheimers disease
8. Optogenetics illuminates pathways of motivation through brain, Stanford study shows
9. Genetics point to serious pregnancy complication
10. Worlds largest respiratory genetics study launches on World COPD Day
11. Genetic link between pancreatitis and alcohol consumption, says Pitt team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... College and university students around the ... new Introduction to Sociology offering, which ... based on each student’s behavior, knowledge, and aptitude. ... adaptive online curriculum resources that individualize each student’s ... general education offerings, enabling institutions to create efficiencies ...
(Date:5/22/2013)... 2013 TheBeautyPlace.com features Toppik and Bosley hair ... any remnants of thinning or balding hair. Hair loss treatments ... appearance of hair loss during this waiting period, one can ... as an alternative to hair transplant surgery in general. ... and an extremely effective way to eliminate the appearance of ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Officials with ... that its cicada services are now in full effect ... that the cicada cycle emerges. , “The cicada ... year that they will emerge, so we’re now offering ... are well protected during the invasion,” said R. Brett ...
(Date:5/22/2013)... 22, 2013 2013 NBA Draft tickets ... Wednesday, May 22, 2013. , The 2013 NBA Draft will be ... the home of the Brooklyn Nets. The Barclays Center has ... Spectacular music artists such as Paul McCartney and Beyonce have already ... Cirque du Soleil will also perform at this state-of-the-art venue. ...
(Date:5/22/2013)... MD (PRWEB) May 22, 2013 According ... is an autoimmune disorder effecting up to 3 million ... causing damage to the small intestine and mal-absorption of ... such as diarrhea, constipation, weight loss and vitamin deficiency, ... diet. While there are many gluten-free foods that celiac ...
Breaking Medicine News(10 mins):Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:TheBeautyPlace.com Divulges Two Innovative Hair Loss Concealers on the Market Today: Bosley Hair Thickening Fibers and Toppik Hair Building Fibers 2Health News:Alliance Commercial Pest Control, Inc. Now Offering Cicada Protection Services 2Health News:2013 NBA Draft Tickets: Cheap Concert Tickets Announces that Official Onsales for the 2013 NBA Draft Begin at 10:00 am Local Time on Wednesday, May 22, 2013 2Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 2Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 3
... a leading global clinical,research organization, is pleased to ... at the JCAHPO annual continuing education,program. Diana who ... Cannula, worked in ophthalmic practice for several years,prior ... (CRA). The,meeting will take place in New Orleans, ...
... 1 The makers of the WaveSense line ... Claudio,Carboni, formerly of Menarini Diagnostics, has joined as ... WaveSense Europe will,distribute the company,s high accuracy, WaveSense ... market both directly and through local,partners. Carboni ...
... MINNEAPOLIS /ST. PAUL (October 31, 2007) According to new ... information in most cases to apply a policy and ... the information. Medicare appears reluctant to aggressively enforce ... are inconsistent with scientific evidence. , By law, Medicare ...
... Video Component Enables Users to Upload Video Confessions/ ... on newfaceofresearch.com for Peer-to-Peer Viewing, PHILADELPHIA and ... Thomson Corporation (NYSE: TOC ; TSX: TOC) ... research and,business communities, today announced the launch of ...
... providing all current services, invest $20 million in ... ... Calif., Oct. 31 Prime Healthcare Services,Inc. (PHS), the owner ... today that Prime Healthcare Centinela, one,of its subsidiaries, has acquired ...
... Health,Services (MHS), a not-for-profit health care system with ... that it has selected,Integrated Healthcare Holdings, Inc. (IHHI) ... a partially physician-owned publicly traded hospital management,company, owns ... a total of,770 beds, 2787 employees and 1725 ...
Cached Medicine News:Health News:Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting 2Health News:Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe 2Health News:U of M study: Medicare lacks tools, incentives to enforce evidence-based coverage policies 2Health News:Thomson Scientific Launches 'Confessions ... of a User' Campaign Asking 'Are You the New Face of Research?' 2Health News:Prime Healthcare Services Acquires Centinela Hospital Medical Center 2Health News:Prime Healthcare Services Acquires Centinela Hospital Medical Center 3Health News:Prime Healthcare Services Acquires Centinela Hospital Medical Center 4Health News:Memorial Health Services Announces Sale of Anaheim Memorial Medical Center 2
(Date:5/22/2013)... , May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... present an overview of the company at the following conferences. ... , Presentation date: Wednesday May 29, 2013 , ... 2013 Global Healthcare Conference , Presentation date: Wednesday June ... A live webcast and 30-day ...
(Date:5/22/2013)... Mass. , May 22, 2013  Flagship ... firm focused on healthcare and sustainability, today announced ... as a Senior Partner. In this role, ... to portfolio companies. In addition to ... Mr. Bancel also serves as President and Chief ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
... Elusys Therapeutics, Inc.,(Elusys), a privately held biopharmaceutical ... life-threatening infectious,diseases, today announced it has been ... development of Anthim(TM), the company,s late-stage anthrax,therapeutic. ... or in part with Federal,funds from the ...
... Trial Aims to Treat Renal Artery Obstructions and Lower ... Pressure in Patients Not Responding to Medication, ... today announced enrollment of the first patient in HERCULES ... and,Safety), a U.S. clinical trial designed to evaluate the ...
Cached Medicine Technology:Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic 2Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis 2Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis 3
Castroviejo microscopic needle holder...
Dilator...
Microscopic scissors, curved...
Microscopic needle holder, curved...
Medicine Products: